Skip to main content

Sleep Disorders

Maternal insomnia increased during the COVID-19 pandemic, with many mothers also reporting mild-to-high levels of acute anxiety related to COVID-19, according to a study published online in the Journal of Sleep Research.

Attention-deficit/hyperactive disorder (ADHD) and narcolepsy may share genetic links, according to an analysis of polygenic risk scores published online in the journal Translational Psychiatry.
Young adults who started using cannabis regularly before age 18 were more likely to report later sleep troubles, according to a study published online in Sleep.
A label update for the insomnia drug Belsomra (suvorexant) C-IV adds study findings on its use in treating insomnia in patients with mild-to-moderate Alzheimer’s disease, drugmaker Merck announced.
The orexin receptor antagonist lemborexant (Dayvigo) has been approved by the US Food and Drug Administration for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adults, Eisai Co. announced.
Back to Top